Literature DB >> 29348477

Thyroid cancer: Balancing benefit and risk in TSH management of DTC.

Frederik A Verburg1, Markus Luster1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348477     DOI： 10.1038/nrendo.2018.1

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.

Authors:  Frederik A Verburg; Johannes W A Smit; Inge Grelle; Theo J Visser; Robin P Peeters; Christoph Reiners
Journal:  Clin Endocrinol (Oxf)       Date:  2012-04       Impact factor: 3.478

2.  Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.

Authors:  Aubrey A Carhill; Danielle R Litofsky; Douglas S Ross; Jacqueline Jonklaas; David S Cooper; James D Brierley; Paul W Ladenson; Kenneth B Ain; Henry G Fein; Bryan R Haugen; James Magner; Monica C Skarulis; David L Steward; Mingxhao Xing; Harry R Maxon; Steven I Sherman
Journal:  J Clin Endocrinol Metab       Date:  2015-07-14       Impact factor: 5.958

3.  Impact of moderate vs stringent TSH suppression on survival in advanced differentiated thyroid carcinoma.

Authors:  Stefanie Diessl; Barbara Holzberger; Uwe Mäder; Inge Grelle; Johannes W A Smit; Andreas K Buck; Christoph Reiners; Frederik A Verburg
Journal:  Clin Endocrinol (Oxf)       Date:  2012-04       Impact factor: 3.478

Review 4.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

5.  The thyroid axis 'setpoints' are significantly altered after long-term suppressive LT4 therapy.

Authors:  F A Verburg; U Mäder; I Grelle; T J Visser; R P Peeters; J W A Smit; C Reiners
Journal:  Horm Metab Res       Date:  2014-05-27       Impact factor: 2.936

6.  Both exogenous subclinical hyperthyroidism and short-term overt hypothyroidism affect myocardial strain in patients with differentiated thyroid carcinoma.

Authors:  Randa M Abdulrahman; Victoria Delgado; Hendrieke C Hoftijzer; Arnold C T Ng; See Hooi Ewe; Nina Ajmone Marsan; Eduard R Holman; Guido C Hovens; Eleonora P Corssmit; Johannes A Romijn; Jeroen J Bax; Johannes W A Smit
Journal:  Thyroid       Date:  2011-03-21       Impact factor: 6.568

7.  Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.

Authors:  Frederik A Verburg; Uwe Mäder; Karina Tanase; Elena-Daphne Thies; Stefanie Diessl; Andreas K Buck; Markus Luster; Christoph Reiners
Journal:  J Clin Endocrinol Metab       Date:  2012-11-12       Impact factor: 5.958

8.  Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer.

Authors:  Nelli Pajamäki; Saara Metso; Tommi Hakala; Tapani Ebeling; Heini Huhtala; Essi Ryödi; Juhani Sand; Arja Jukkola-Vuorinen; Pirkko-Liisa Kellokumpu-Lehtinen; Pia Jaatinen
Journal:  Clin Endocrinol (Oxf)       Date:  2017-12-14       Impact factor: 3.478

9.  Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer.

Authors:  Guido C Hovens; Marcel P Stokkel; Job Kievit; Eleonora P Corssmit; Alberto M Pereira; Johannes A Romijn; Johannes W A Smit
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

10.  The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study.

Authors:  Christian Selmer; Jonas Bjerring Olesen; Morten Lock Hansen; Jesper Lindhardsen; Anne-Marie Schjerning Olsen; Jesper Clausager Madsen; Jens Faber; Peter Riis Hansen; Ole Dyg Pedersen; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  BMJ       Date:  2012-11-27
  10 in total
  1 in total

1.  An 8 miRNA-Based Risk Score System for Predicting the Prognosis of Patients With Papillary Thyroid Cancer.

Authors:  Wanwan Yi; Jin Liu; Shuping Qu; Hengwei Fan; Zhongwei Lv
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.